IDEAYA Biosciences, Inc.
IDYA· Nasdaq
IDYAIDEAYA Biosciences, Inc.
Filed Mar 18, 2022 · 10-K · 77 days after period end · 0001564590-22-010922
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $2.96M | — | — | — |
| Net Income | -$18.21M | -$5.14M | -$10.78M | -$8.56M |
| EPS Diluted | — | — | -$0.53 | -$8.11 |
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Mar 18, 2022 · 77 d after period end
